Results 141 to 150 of about 23,963 (194)

Safety and efficacy of oral cladribine in relapsing multiple sclerosis: a systematic review and meta-analysis. [PDF]

BMC Neurol
Alnajashi H, Almohammed HAJ, Morad AS, Bin Saddiq BW, Kushara KF, Al Zoabi BMK, Aldawsari WA, Almuhaysin FI, Gasim MA, Alharbi HA, Khan TN.   +10 more
europepmc   +1 more source

B-cell-driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review. [PDF]

Front Immunol
Bruno PA, Barone S, Pascarella A, Lanza PL, Tinelli E, Gambardella A, Valentino P.   +6 more
europepmc   +1 more source

Challenging The Diagnosis of Multiple Sclerosis: Histopathological Insights Gained Through Brain Biopsies. [PDF]

Noro Psikiyatr Ars
Taşkıran E, Öztürk B, Ata N, Birinci Ş, Emekli AS, Kürtüncü M.   +5 more
europepmc   +1 more source

The gut microbiota composition is shaped by disease activity and individual treatment responses in patients with multiple sclerosis. [PDF]

Front Immunol
Ticha V, Coufal S, Jiraskova Zakostelska Z, Thon T, Roubalova R, Hrncir T, Kverka M, Pavelcova M, Kleinova P, Lizrova Preiningerova J, Kovarova I, Kreisinger J, Tlaskalova-Hogenova H, Kubala Havrdova E.   +13 more
europepmc   +1 more source

A fingolimod cardiovascularis hatásának klinikai jelentősége a sclerosis multiplex kezelésében [PDF]

, 2012
Merkely, Béla Péter, Széplaki, Gábor
core  

Depression, Anxiety, and MSQOL-54 Outcomes in RRMS Patients Receiving Fingolimod or Cladribine: A Cross-Sectional Comparative Study. [PDF]

Medicina (Kaunas)
Özbek M, Arıkanoğlu A, Aluçlu MU.
europepmc   +1 more source

Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis. [PDF]

Eur J Neurol
Moradi N, Sharmin S, Malpas CB, Kuhle J, Benkert P, Leppert D, Havrdová EK, Horáková D, Kleinová P, Uher T, Manouchehrinia A, Hillert J, Olsson T, Kochum I, Taylor BV, Barnett M, Kilpatrick TJ, Buzzard K, Kalincik T.   +18 more
europepmc   +1 more source

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study. [PDF]

J Neurol
Maniscalco GT, Sparaco M, Di Gregorio M, Cafasso G, Signoriello E, Romano F, Iodice R, Fantozzi R, Bellantonio P, Zanghi A, Sinisi L, D'Ambrosio A, Busillo V, Scarano V, Capuano R, Lavorgna L, Williams M, De Martino A, Di Battista ME, Di Giulio Cesare D, Lus G, Cassano E, Di Filippo PS, Sibilia G, Abbadessa G, Andreone V, Bonavita S.   +26 more
europepmc   +1 more source